STING1 and neoplasm: STING activation is reported to drive carcinogenesis by creating tumor-prone inflammatory conditions or inhibiting T cell mediated anti-tumor immunity effects (Ahn et al., 2014a; Ahn et al., 2014b; Larkin et al., 2017).